tradingkey.logo

Treace Medical Concepts Inc

TMCI

7.190USD

+0.150+2.13%
終値 09/18, 16:00ET15分遅れの株価
453.27M時価総額
損失額直近12ヶ月PER

Treace Medical Concepts Inc

7.190

+0.150+2.13%
詳細情報 Treace Medical Concepts Inc 企業名
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
企業情報
企業コードTMCI
会社名Treace Medical Concepts Inc
上場日Apr 23, 2021
最高経営責任者「CEO」Mr. John T. Treace
従業員数477
証券種類Ordinary Share
決算期末Apr 23
本社所在地100 Palmetto Park Place
都市PONTE VEDRA
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号32081
電話番号19043735940
ウェブサイトhttps://www.treace.com/
企業コードTMCI
上場日Apr 23, 2021
最高経営責任者「CEO」Mr. John T. Treace
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.61K
-13.55%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
42.87K
-19.70%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.61K
-13.55%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
42.87K
-19.70%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Treace (John T.)
18.53%
Armistice Capital LLC
9.91%
BlackRock Institutional Trust Company, N.A.
5.20%
William Blair Investment Management, LLC
4.91%
The Vanguard Group, Inc.
4.31%
他の
57.14%
株主統計
株主統計
比率
Treace (John T.)
18.53%
Armistice Capital LLC
9.91%
BlackRock Institutional Trust Company, N.A.
5.20%
William Blair Investment Management, LLC
4.91%
The Vanguard Group, Inc.
4.31%
他の
57.14%
種類
株主統計
比率
Individual Investor
25.71%
Investment Advisor/Hedge Fund
21.77%
Hedge Fund
18.18%
Investment Advisor
18.08%
Research Firm
2.74%
Bank and Trust
0.32%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
他の
13.11%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
2023Q1
265
55.41M
90.97%
+228.07K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Treace (John T.)
11.70M
18.61%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.21M
9.87%
+2.00K
+0.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.40M
5.41%
+14.71K
+0.43%
Mar 31, 2025
William Blair Investment Management, LLC
3.06M
4.87%
+121.76K
+4.14%
Mar 31, 2025
The Vanguard Group, Inc.
2.71M
4.3%
-27.56K
-1.01%
Mar 31, 2025
Gagnon Securities LLC
2.71M
4.31%
+963.43K
+55.16%
May 09, 2025
Treace (James T)
1.78M
2.83%
--
--
Mar 24, 2025
CIBC Private Wealth Management
2.29M
3.65%
+405.26K
+21.46%
Mar 31, 2025
JP Morgan Asset Management
1.40M
2.22%
-93.94K
-6.29%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI